I
ImmunityBio, Inc. (IBRX)
NMS – Real vaqt narxi. Valyuta: USD
7.74
+0.14 (1.84%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
7.74
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 7:09 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NMS – Real vaqt narxi. Valyuta: USD
7.74
+0.14 (1.84%)
Yopilishda: Aug 12, 2026, 3:59 PM EDT
7.74
0.00 (0.00%)
Bozordan keyin: Aug 12, 2026, 7:09 PM EDT
No Data
Ushbu aksiya uchun yangiliklar yo'q.
Naqd pul zahiralari $0.0 kelgusi qarz to'lovlarini $0.0 zo'rg'a qoplaydi
Jami joriy aktivlar $0.0 jami joriy majburiyatlarni $0.0 zo'rg'a qoplaydi, bu cheklangan likvidlikni ko'rsatadi
Qarz/kapital nisbati (0.0) tarmoq o'rtachasiga yaqin bo'lib, muvozanatli leverajni aks ettiradi
Foiz xarajatlari mavjud, ammo EBIT ma'lumotlari mavjud emas, bu potentsial rentabellik muammolarini ko'rsatadi
| KO‘RSATKICH NOMI | KO‘RSATKICH | SANOAT O‘RTACHASI | 5 YILLIK TREND | BALL |
|---|---|---|---|---|
| Joriy likvidlik ko'rsatkichi | N/A | 6.05 | 1.0 | |
| Tezkor likvidlik nisbati | N/A | 5.63 | 1.0 | |
| Qarz/Kapital nisbati | N/A | 0.30 | 1.0 | |
| Qarz/Aktivlar nisbati | N/A | 1.04 | 1.0 | |
| Foiz to‘lov qoplami | N/A | -16.91 | 1.0 | |
| O‘rtacha ball | 1.0 | |||
| KO‘RSATKICH | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Jami daromad | 240K | 622K | 15M | 113M | 115M |
| Yalpi foyda | -24M | -18M | -3M | 97M | 102M |
| Operatsion daromad | -351M | -361M | -344M | -256M | -252M |
| Sof foyda | -417M | -583M | -414M | -351M | -992M |
| EBITDA | -326M | -343M | -327M | -241M | -178M |
| Nomi | DAROMAD O'SISHI | EPS O‘SISHI | BALL |
|---|---|---|---|
| Joriy chorak | 84.73 | 0 | 5.5 |
| Keyingi chorak | 86.01 | -8.33 | 5.5 |
| Joriy yil | 99.12 | -152.63 | 5.5 |
| Keyingi yil | 95.7 | 85.16 | 10 |
| O‘rtacha ball | 6.6 | ||
| NOMI | DAROMAD | SOF FOYDA | EPS | FCF | BALL |
|---|---|---|---|---|---|
| Chorak/Chorak | 15.47 | 63.59 | 64.52 | -8.27 | 7.5 |
| Yil/Yil | 167.64 | -148.9 | -119.99 | 11.35 | 4.8 |
| 3 yil o‘rtacha | 1032.69 | 1.38 | 24.74 | 8.89 | 7.3 |
| 5 yil o‘rtacha | 753.04 | -58.26 | 11.48 | -65.92 | 4.8 |
| O‘rtacha ball | 6.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NOMI | JORIY | SANOAT | BALL |
|---|---|---|---|
| Dividend foizi | 0.00 | N/A | 1.0 |
| To'lov koeffitsienti | 0.00 | N/A | 1.0 |
| 5 yillik dividend o‘sishi | N/A | N/A | 1.0 |
| Dividend oshgan yillar | N/A | N/A | 1.0 |
| O‘rtacha ball | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NOMI | MASSHTAB | BALL |
|---|---|---|
| Bozor ulushi | Yo'q | 1.0 |
| Nomoddiy aktivlar | O'rtacha | 7.0 |
| O'zgartirish xarajatlari | Yo'q | 1.0 |
| Tarmoq ta'siri | Yo'q | 1.0 |
| Masshtab ta'siri | Yo'q | 1.0 |
| O‘rtacha ball | 2.2 | |